Literature DB >> 19787587

Prospective study of risk factors for conjunctival bacterial contamination in patients undergoing intraocular surgery.

Herminia Miño De Kaspar1, Christopher N Ta, Stephan J Froehlich, Ulrich C Schaller, Michael Engelbert, Volker Klauss, Anselm Kampik.   

Abstract

PURPOSE: To determine whether a patient's age, gender, local or systemic risk factors affect the rate of preoperative bacterial contamination.
METHODS: Consecutive 1,474 patients undergoing intraocular surgery were enrolled in this prospective masked study. Past medical history was noted and examinations were performed. The patients were divided into four groups: a control group (without local or systemic risk factors), those with local risk factors (chronic use of topical medications, contact lens wear, blepharitis, chronic eyelid or conjunctival inflammation), those with systemic risk factors (immunosuppression, diabetes, autoimmune conditions, and asthma), and those with both. Conjunctival cultures were obtained before surgery.
RESULTS: Among the 1,474 patients, 914 bacteria were isolated from 214 (14.9%) patients. Advanced age was associated with a higher rate of positive conjunctival cultures (p<0.005). No statistical difference was found with regard to gender (p=0.7173). Among the 282 patients in the control group, 14 (5%) had a positive conjunctival culture. Compared to the control group, positive conjunctival cultures were found in 118 out of 503 patients (23.5%) with local risk factors (p<0.0001), 65 out of 545 patients (11.9%) with systemic risk factors (p=0.0019), and 22 out of 144 (15.3%) with both (p=0.0006). Two patients developed postoperative endophthalmitis (0.14%), one with both local risk and systemic factors and the other with a systemic risk factor.
CONCLUSIONS: Patients with local or systemic risk factors or advanced age were found to have a higher rate of bacterial conjunctival contamination before intraocular surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19787587     DOI: 10.1177/112067210901900505

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  8 in total

1.  Risk factors for aerobic bacterial conjunctival flora in preoperative cataract patients.

Authors:  S Hoshi; M Hashida; K Urabe
Journal:  Eye (Lond)       Date:  2016-07-15       Impact factor: 3.775

2.  Management strategies to reduce risk of postoperative infections.

Authors:  Anat Galor; Raquel Goldhardt; Sarah R Wellik; Ninel Z Gregori; Harry W Flynn
Journal:  Curr Ophthalmol Rep       Date:  2013-12

3.  Pathogenic conjunctival bacteria associated with systemic co-morbidities of patients undergoing cataract surgery.

Authors:  M-E Fernández-Rubio; T Cuesta-Rodríguez; J-L Urcelay-Segura; C Cortés-Valdés
Journal:  Eye (Lond)       Date:  2013-05-24       Impact factor: 3.775

4.  Positive bacterial culture in conjunctival sac before cataract surgery with night stay is related to diabetes mellitus.

Authors:  Tetsuhiro Kawata; Toshihiko Matsuo
Journal:  BMC Ophthalmol       Date:  2017-02-20       Impact factor: 2.209

Review 5.  The ocular surface bacterial contamination and its management in the prophylaxis of post cataract surgery endophthalmitis.

Authors:  Daniela Soare Simina; Ilie Larisa; Costeliu Otilia; Ghiță Ana Cristina; Mary Voinea Liliana; Mihai Ghiță Aurelian
Journal:  Rom J Ophthalmol       Date:  2021 Jan-Mar

6.  Conjunctival sac bacterial culture of patients using levofloxacin eye drops before cataract surgery: a real-world, retrospective study.

Authors:  Zhenyu Wang; Pei Zhang; Chen Huang; Yining Guo; Xuhe Dong; Xuemin Li
Journal:  BMC Ophthalmol       Date:  2022-07-30       Impact factor: 2.086

7.  Research Trends and Hotspot Analysis of Conjunctival Bacteria Based on CiteSpace Software.

Authors:  Zhenyu Wang; Chen Huang; Xuemin Li
Journal:  Biomed Res Int       Date:  2020-10-05       Impact factor: 3.411

8.  Composition and Diversity of the Ocular Surface Microbiota in Patients With Blepharitis in Northwestern China.

Authors:  Changhao Wang; Xiuhong Dou; Jian Li; Jie Wu; Yan Cheng; Na An
Journal:  Front Med (Lausanne)       Date:  2021-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.